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Functional expression of the eotaxin receptor CCR3 in
T lymphocytes co-localizing with eosinophils
B.O. Gerber*, M.P. Zanni†, M. Uguccioni*, M. Loetscher*, C.R. Mackay‡, 
W.J. Pichler†, N. Yawalkar†, M. Baggiolini* and B. Moser*
Background: The chemokine eotaxin is produced at sites of allergic inflammation,
binds selectively to the chemokine receptor CCR3 and attracts eosinophil and
basophil leukocytes, which express high numbers of this receptor. Responses of
T lymphocytes to eotaxin have not been reported so far. We have investigated the
expression of CCR3 in T lymphocytes and analysed the properties and in vivo
distribution of T lymphocytes expressing this receptor.
Results: In search of chemokine receptors with selective expression in
T lymphocytes, we have isolated multiple complementary DNAs (cDNAs)
encoding CCR3 from a human CD4+ T-cell cDNA library. T-lymphocyte clones
with selectivities for protein and non-protein antigens were analysed for
expression of CCR3 and production of Th1- and Th2-type cytokines. Of 13
clones with surface CCR3, nine secreted enhanced levels of interleukin-4
and/or interleukin-5, indicating that CCR3 predominates in Th2-type
lymphocytes. CCR3+ T lymphocytes readily migrated in response to eotaxin,
and showed the characteristic changes in cytosolic free calcium.
Immunostaining of contact dermatitis, nasal polyp and ulcerative colitis tissue
showed that CCR3+ T lymphocytes are recruited together with eosinophils and,
as assessed by flow cytometry, a large proportion of CD3+ cells extracted from
the inflamed skin tissue were CCR3+. By contrast, CCR3+ T lymphocytes were
absent from tissues that lack eosinophils, as demonstrated for normal skin and
rheumatoid arthritis synovium.
Conclusions: We show that T lymphocytes co-localizing with eosinophils at
sites of allergic inflammation express CCR3, suggesting that eotaxin/CCR3
represents a novel mechanism of T-lymphocyte recruitment. These cells are
essential in allergic inflammation, as mice lacking mature T lymphocytes were
insensitive to allergen challenge. Surface CCR3 may mark a subset of
T lymphocytes that induce eosinophil mobilization and activation through local
production of Th2-type cytokines.
Background
The typical cellular infiltrate of allergic inflammation con-
sists mainly of eosinophils, T lymphocytes and occasional
basophils. These leukocytes are recruited by chemokines
that are produced in the affected tissue by resident or
immigrant cells [1–3]. Eosinophils migrate in response to
the CC chemokines eotaxin [4,5] and RANTES [6,7] and
the monocyte chemotactic proteins MCP-2 [8], MCP-3 [9]
and MCP-4 [10]. 
Eotaxin was originally identified in the bronchoalveolar
lavage fluid of ovalbumin-sensitized guinea-pigs [11–13]
and was later found in the mouse [14] and in man 
[5]. Human eotaxin is structurally related to the MCPs
sequence identity), and is a potent chemoattractant for
eosinophils which express large numbers of the eotaxin
receptor CCR3 [15–17]. Like all other known chemokine
receptors, CCR3 belongs to the family of seven-trans-
membrane domain receptors, which couple to G proteins
for signal transduction [1,2,18,19]. In addition to eotaxin,
CCR3 binds RANTES, MCP-2, MCP-3 and MCP-4
[10,15–17,20]. However, eotaxin is highly selective for
CCR3, whereas RANTES and the MCPs recognize addi-
tional chemokine receptors that are expressed on mono-
cytes, granulocytes, natural killer cells and T lymphocytes
[1–3]. Eotaxin was recently shown to mediate histamine
release in basophils, which also express CCR3 [20–22], but
responses of T lymphocytes were not reported. Studies of
eosinophil mobilization in guinea-pig and murine models of
allergic inflammation emphasize the critical role of eotaxin
in the regulation of allergic responses [4,12,23–25]. Notably,
in eotaxin-deficient mice and in animals treated with neu-
tralizing antibodies to eotaxin, allergen-induced eosinophil
invasion of the airways was drastically reduced [24,26].
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Unlike monocytes and granulocytes, the majority of
freshly isolated peripheral T lymphocytes do not respond
to chemokines [1,2,27]. Culturing in the presence of inter-
leukin-2 (IL-2), however, results in polyclonal expansion
of activated CD45RO+ T cells that express the relevant
chemokine receptors and readily respond to chemokines
[28,29]. The IL-2-treated T lymphocytes resemble the
lymphocytes that are recruited through locally produced
chemokines during immune reactions. 
In search of chemokine receptors with selective expres-
sion in T lymphocytes, we have recovered full-length
cDNAs for known and novel chemokine receptors from a
human CD4+ T-cell line cDNA library. One cDNA
encoded CXCR3, the receptor for the CXC chemokines
IP10 and Mig and which is exclusively found on activated
T cells [29]. In addition, we have isolated several cDNA
clones encoding CCR3. In view of the current understand-
ing that eotaxin is selective for eosinophils and basophils,
this finding was surprising. Here we demonstrate that
CCR3 expression defines a subset of T lymphocytes that
respond to eotaxin and co-localize with eosinophils at sites
of allergic inflammation.
Results and discussion
Cloning of CCR3 and functional expression in T lymphocytes
In the course of screening a human CD4+ T-cell cDNA
library with a PCR-amplified DNA probe we identified no
fewer than eight cDNA clones encoding the eotaxin
receptor CCR3. A nucleotide fragment corresponding to
part of the CCR3 coding sequence was used as a
hybridization probe in northern blot analysis. In agree-
ment with previous reports [15–17], abundant CCR3 tran-
scripts could be demonstrated in eosinophils, whereas
neutrophils, monocytes or freshly isolated blood lympho-
cytes were negative (not shown). T lymphocyte responses
to chemokines depend on cell activation, and IL-2 was
shown to induce the expression of CCR1 and CCR2 [28]
as well as CXCR3 [29]. IL-2 treatment did not enhance
the expression of CCR3. Occasionally, however, low levels
of CCR3 transcripts were observed in these cultures, sug-
gesting that CCR3 is present in a subset of circulating
T lymphocytes.
Skin hypersensitivity responses to various drugs, such as
antibiotics, anaesthetics or anti-epileptics, are characterized
by a cellular infiltrate consisting mainly of eosinophils and
T lymphocytes [30]. Cloned T lymphocytes generated
from peripheral blood lymphocytes of patients who develop
contact dermatitis after topical application of lidocaine [31]
were analysed for CCR3 expression. On the basis of their
clonality, cytokine pattern and in vitro cell growth, four
CD4+ T-lymphocyte clones — B22, OFB2, B24 and D21
— were selected for further study. Clonality was deter-
mined with a panel of 17 different monoclonal antibodies
recognizing the Vβ chain of the T-cell receptor (TCR) and
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Figure 1
CCR3 expression in human T-lymphocyte
clones. (a) Northern blot of CCR3 (top panel)
and CCR2 (middle panel) mRNA. Ethidium
bromide staining of total RNA in the agarose
gel prior to blotting is shown in the bottom
panel. One of two independent experiments is
shown. (b) Flow cytometric analysis with
anti-CCR3 monoclonal antibody (bold trace)
or isotype control immunoglobulins (fine
trace). One of three independent experiments
is shown.
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PCR-based TCR Vβ expression analysis. The TCR speci-
ficity of the clones was Vβ17 for OFB2, Vβ12 for B22,
Vβ5.1 for B24 and Vβ13.1 and 13.2 for D21. Northern blot
analysis showed the presence of transcripts for CCR3 in all
four clones (Figure 1a). Transcripts for CCR2, which is
upregulated in T lymphocytes by stimulation with IL-2
[28], were also detected. In addition, the expression of
CCR3 was studied by flow cytometry using the selective
antibody 7B11 [32]. The clones B24, B22 and OFB2 were
strongly positive, whereas D21 expressed only low levels
of CCR3 protein (Figure 1b). To show that CCR3 was
functional, [Ca2+]i changes and chemotaxis were measured
after stimulation with the selective ligand eotaxin. As
shown in Figure 2, Ca2+ mobilization was observed in all
four clones, whereas chemotaxis was observed in B22, B24
and OFB2, the clones expressing high levels of CCR3.
The migration response was typically bimodal with
respect to chemokine concentration and maximum effi-
cacy was reached at 1 nM. The responses were prevented
by pretreatment of the cells with the CCR3-blocking anti-
body 7B11 [32]. All four clones also responded to MCP-1,
which acts through CCR2 [33], and this response was not
affected by the anti-CCR3 monoclonal antibody (Figure
2a). Eotaxin and MCP-1 were equally effective in induc-
ing [Ca2+]i changes. As expected, in view of the receptor
selectivity of the two chemokines, no cross-desensitization
was found (Figure 2b).
CCR3 expression in cultured T-lymphocyte clones
A total of 32 T-lymphocyte clones with selectivity for lido-
caine (11 clones), sulfamethoxazole (7 clones), purified
protein derivative of Mycobacterium tuberculosis (4 clones) or
tetanus toxoid protein (10 clones) were analysed for
expression of CCR3 (Table 1). The production of inter-
feron-γ (IFN-γ) as marker for Th1 cells, or IL-4 and IL-5
as markers for Th2 cells was determined in a total of 24
clones. Of these, 13 expressed high levels of CCR3, and
nine of them also secreted enhanced levels of IL-4 and/or
IL-5. This indicates that CCR3 expression predominates
in T lymphocytes that produce Th2-type cytokines. The
frequent expression of CCR3 in T lymphocytes specific
for topically applied lidocaine may imply that these cells
are important in allergic inflammation of the skin or
mucosal/epithelial tissue. 
CCR3+ T lymphocytes in inflammatory diseases
Skin sections from patients with contact dermatitis
induced by topical application of lidocaine or nickel were
analysed by immunohistochemistry for the presence of
infiltrating cells that were positive for CD3, CCR3 and
eotaxin. In the perivascular areas, eosinophils (identified
by haematoxylin/eosin staining) and T lymphocytes (CD3+)
were frequent. Most cells in these areas were also positive
for CCR3, and eotaxin was readily detected throughout
the lesions. T lymphocytes, eosinophils and CCR3+ cells
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Figure 2
Responses of human T-lymphocyte clones to eotaxin and MCP-1. 
(a) In vitro chemotaxis. The assay was performed in the presence (open
symbols) or absence (closed symbols) of anti-CCR3 monoclonal
antibody and increasing concentrations of eotaxin (triangles) or MCP-1
(circles). The number of cells that migrated in the absence of chemokines
is also shown (diamonds). Mean number (± s.d.) of migrating cells per
five high-power fields are presented from one out of three independent
experiments. (b) Eotaxin- and MCP-1-induced [Ca2+]i changes. Agonists
were added at 100 nM at 0 sec and 80 sec as indicated by the
arrowheads. One of two independent experiments is shown.
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were counted in serial sections and their frequency was
calculated (Table 2). In contrast, only few CD3+ cells
and no CCR3+ cells were found in normal skin. Cluster-
ing of the infiltrating cells prevented a clear-cut identifi-
cation of cells positive for both CD3 and CCR3 in
double-stained sections. However, CCR3+ T lympho-
cytes were readily recovered by trypsin treatment of a
contact dermatitis biopsy as shown by flow cytometry
(Figure 3). About 20% of CD3+ T lymphocytes derived
from inflamed skin expressed CCR3, which is in keeping
with the frequency of CCR3+ infiltrating cells other than
eosinophils (Table 2). 
The phenotype of T lymphocytes co-localizing with eosino-
phils was further examined in biopsies from nasal polyps
and ulcerative colitis, which are inflammatory conditions
with marked eosinophil infiltration [5,34]. Analysis of tissue
sections from nasal polyps revealed large numbers of
T lymphocytes and eosinophils. Serial sections stained for
CD3 or CCR3 are shown in Figure 4 a,b. Double staining
for CD3 and CCR3 was also performed. Double-positive
T lymphocytes (T+) along with eosinophils (E) and
CD3+/CCR3- cells (T–) were present (Figure 4c). Eosino-
phils are recognized by their typical nucleus and blue
staining for surface CCR3 and CCR3-negative T lympho-
cytes by their bright red staining for surface CD3. A
double-positive T lymphocyte (T+) is shown at higher
magnification (Figure 4c inset). T lymphocytes expressing
CCR3 were always found in association with eosinophils,
whereas T lymphocyte clusters without eosinophils were
always CCR3-negative. T lymphocytes in areas rich in
Table 1
CCR3 expression by human T-lymphocyte clones.
Clone Ref.* Antigen† Cluster‡ IFN-γ§ IL-4§ IL-5§ CCR3¶
B24 [31] LC CD4+ 211 12 17 +
B22 [31] CD4+ 11 39 285 +
D21 [31] CD4+ 225 35 15 +/–
OFB2 [31] CD4+ 15 67 210 +
G6 [31] CD4+ 4 5.4 20.6 +
G7 [31] CD4+ 13 8.7 52.2 +
I39 [31] CD4+ 6.5 19.5 83.7 +
LI35 [31] CD4+ 3.6 11.9 113.3 +
LK19 [31] CD4+ 3.6 33 177 +/–
K58 CD4+ 42.3 3.5 60.5 +/–
OFZ45 CD4+ 13.5 3.7 127 +
P102B SM CD4+ 14 12 <1 +
P103C CD8+ 87.2 0.3 7.1 –
P21E CD4+ 22 28 16 –
P26B [39] CD8+ 183 0.5 26 –
S1011E [39] CD4+ 40 68 25 –
S211A CD8+ 83 0.7 36.6 +
S23E [39] CD4+ 17 13 15 –
PD4 PPD** CD4+ –
PD22 CD4+ –
PD24 CD4+ –
PD20 CD4+ –
C6 [40] TT CD4+ –
C24 [40] CD8+ 50 48 +
C38 [40] CD4+ 150 26 –
KT30 [41] CD4+ +
Q16 CD4+ 95 0.9 2.3 –
O35 CD4+ 5 10 41 –
O45 CD4+ 172 13.8 38.2 –
TT10 CD4+ +/–
TT21 CD4+ –
TT24 CD4+ 118.6 24 68.3 +
*No reference means that the clone is unpublished. †T-cell clones are
specific for lidocaine (LC); sulfamethoxazole (SM); purified protein
derivative of M. tuberculosis (PPD); tetanus toxoid (TT). ‡Cluster of
differentiation antigen. §Cytokine production in culture (ng ml–1).
¶CCR3 expression < D21 (–); CCR3 expression = D21 (+/–);
CCR3 expression < D21 (+) (see Figure 1). **The majority of T-cell
clones specific for PPD have a Th1 profile as previously shown [46].
Figure 3
Identification of CCR3+ T lymphocytes extracted from a contact
dermatitis lesion. Flow cytometric analysis with (a) anti-CD3, and (b)
anti-CCR3 monoclonal antibodies (bold trace) or isotype control
immunoglobulins (fine traces).
eosinophils as well as the CD3+/CCR3+ cells were counted
and found to amount to 12–15% of the total count
(Table 3). In confirmation of previous results, nasal polyp
specimens were also regularly positive for eotaxin [5]. 
Colon mucosa biopsies from patients with ulcerative colitis
showed massive infiltration of CD3+ and CCR3+ cells
(Table 2) and high levels of eotaxin (Figure 4d–f). In this
case, double staining could not be performed because
endogenous alkaline phosphatase interferes with the
detection system used. As in contact dermatitis and nasal
polyps, CCR3+ T lymphocytes and eosinophils were found
again in close proximity. In contrast, no CCR3+ cells were
found in synovial tissue from patients with rheumatoid
arthritis, which is strongly infiltrated by T lymphocytes
but lacks eosinophils (Table 2). This result further
indicates that infiltration by CCR3+ T lymphocytes is
characteristic of allergic inflammation.
Which types of T lymphocyte express CCR3 and are
attracted by eotaxin? Chemokine receptors, including
CXCR3, CCR1, CCR2 and CCR5, are expressed by the
majority of peripheral blood CD45RO+ T lymphocytes
after IL-2 stimulation [28,29], whereas CCR3+ T lym-
phocytes constituted a minor fraction in these cultures.
Screening of 32 T-lymphocyte clones with specificity for
various peptide and non-peptide antigens revealed that all
lidocaine-specific T-cell clones were CCR3+ (Table 1).
CCR3 expression was much less frequent in T lympho-
cyte clones specific for sulfamethoxazole or protein anti-
gens. Possibly, the route of antigen application (topical as
opposed to systemic) rather than the chemical nature of
the antigen determines the expansion and mobilization of
CCR3+ T lymphocytes. 
Conclusions
Our findings demonstrate that in allergic inflammation,
T lymphocytes are recruited together with eosinophils by
way of CCR3. T lymphocytes have a decisive role in allergic
inflammation, as documented in CD3- and CD4-deficient
mice, which show severely reduced eosinophil mobilization
after allergen challenge [24,35]. Through local production of
Th2-type cytokines, CCR3+ T lymphocytes are likely to
fulfil several functions, including the induction of adhesion
molecules in the microvasculature that are required for
eosinophil diapedesis and for the  priming and prolonged
survival of eosinophils [24]. We propose that these essential
functions are triggered and maintained by CCR3+ T lym-
phocytes, whose population is expanded and recruited as a
consequence of allergen challenge. CCR3 expression in
T lymphocytes may serve as a marker for evaluating an
individual’s predisposition to allergic inflammation and as a
target for therapeutic intervention.
Materials and methods
Cell isolation and T-lymphocyte clones
Human neutrophils, monocytes and lymphocytes were isolated from
buffy coats [36–38]. T-lymphocyte clones were established and 
characterized as described [31,39–41]. IL-4, IL-5 and INF-γ were deter-
mined in the supernatant of the T-cell clones (106 cells) stimulated with
10 ng ml–1 PMA and 0.5 µg ml–1 ionomycin for 24 h [31,39,40]. For the
characterization of CCR3 expression, clones were cultured for 6–7 days
in the presence of 20 U ml–1 recombinant and 20 U ml–1 natural IL-2.
For isolation of resident leukocytes from inflamed skin, a 5 mm punch
biopsy was taken from a patient with contact dermatitis and kept in
0.25% trypsin for 8 h at 4°C [42]. A cell suspension was obtained by
mechanical disaggregation. T cells were resuspended in RPMI 1640,
10% human AB serum (Swiss Red Cross Laboratory) and stimulated with
1 µg ml–1 phytohaemagglutinin (PHA) in the presence of irradiated feeder
cells for 24 h. After 3 days of culture in the presence of 20 U ml–1 rIL-2,
cells were analysed for CCR3 and CD3 expression by flow cytometry.
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Table 2
Analysis of CCR3+ cells in serial tissue sections obtained from patients with allergic and non-allergic inflammation.
Contact dermatitis Ulcerative colitis Rheumatoid arthritis
Patient CCR3+ Eosinophils CD3+ Patient CCR3+ Eosinophils CD3+ Patient CCR3+ Eosinophils CD3+
1 166 59 337 1 625 263 651 1 0 0 416
2 88 20 644 2 307 121 536 2 0 0 569
3 83 22 283 3 275 222 340
T cells, eosinophils and CCR3+ cells were counted in serial sections of contact dermatitis, ulcerative colitis, and rheumatoid arthritis samples. The
same fields were evaluated at 40x magnification. The numbers of cells per mm2 are shown.
Table 3
Analysis of CCR3+ cells in double-stained tissue sections of
nasal polyps.
Patient CCR3+/CD3+ Eosinophils CD3+
1 40 (14) 148 (52) 135 (48)
2 37 (12) 135 (45) 167 (55)
3 38 (15) 133 (46) 145 (54)
Co-localizing T cells and eosinophils and cells co-expressing CD3 and
CCR3 were counted in nasal polyp sections. Nine fields of each
double-stained section were analysed at 40x magnification. The
numbers of cells per mm2 and the percentage of the total number of
counted cells (in brackets) are shown.
CCR3 cDNA isolation and northern blot analysis
For generation of CCR3 DNA fragments, two degenerate primers:
5′-GGGCTGCAG(C/A)GITAC(C/G)TGGCCATIGT(C/G)C-3′;
5′-GGGTCTAGAIGGGTTIAI(G/A)CA(G/A)C(T/A)(G/A)(T/C)G-3′;
(I = inosine)
corresponding to conserved sequence motifs in known chemokine
receptors were used in PCR amplifications with human genomic DNA
as template, and products of expected size were subcloned and
sequenced [29]. An amplified CCR3 DNA was used as probe to
isolate full-length cDNAs from a human tetanus toxoid-specific CD4+
T-cell cDNA library [29]. The eight individual cDNA clones contained
three different 5′-untranslated regions (UTRs) with two putative mRNA
splicing sites, indicating that the variant 5′-UTRs were derived from
alternative mRNA processing. For northern blot analysis, samples of
15 µg total RNA were fractionated by agarose gel electrophoresis and
vacuum blotted [29]. As hybridization probes, a 1.3 kb BamHI–XbaI
fragment of the CCR3 cDNA and a 0.5 kb BstXI–BglII fragment of the
CCR2 cDNA were used. Blots were analysed on a PhosphorImager
(Molecular Dynamics).
Flow cytometry
T lymphocytes were incubated with anti-CCR3 monoclonal antibody
7B11 or anti-CD3 (Dako) or IgG2a mouse immunoglobulins (Sigma)
on ice and washed before addition of fluorescein isothiocyanate
(FITC)-conjugated rabbit anti-mouse antibody (DAKO). Paraform-
aldehyde-fixed cells were analysed by flow cytometry (FACScan,
Becton Dickinson).
T lymphocyte responses
Chemotaxis was performed in 48-well microchambers (NeuroProbe)
with 105 cells per well in RPMI 1640, 20 mM Hepes pH 7.4 and 1%
pasteurized human plasma protein solution (Swiss Red Cross Labora-
tory) using collagen-precoated polycarbonate membranes (Poretics)
with 3 µm pores [28]. Where indicated, cells were preincubated at
room temperature for 20 min with anti-CCR3 monoclonal antibody
7B11 at 10 µg ml–1.
Changes in cytosolic free calcium concentrations ([Ca2+]i) were deter-
mined in Fura-2-loaded cells as described [29]. Briefly, T-lymphocyte
clones (3 × 106 ml–1) were incubated with 0.1 nmol Fura-2/AM for
30 min at 37°C, and after washing stimulated with a chemokine as 
indicated. [Ca2+]i-related fluorescence changes were recorded [43].
Immunohistochemistry
Tissue samples obtained from patients with contact dermatitis, nasal
polyps, ulcerative colitis and rheumatoid arthritis were analysed.
Cryostatic sections of 4 µm (8 µm for nasal polyps) were fixed and
stained as described [30,44]. For contact dermatitis, nasal polyp and
rheumatoid arthritis samples, an alkaline phosphatase detection system
was used; for ulcerative colitis a peroxidase detection system was used.
Endogenous peroxide activity in colon mucosa was blocked with
1% hydrogen peroxide in PBS/saponin 0.1% at room temperature for
1 h. The tissue sections were incubated overnight with one of the follow-
ing monoclonal antibodies: anti-CCR3 7B11 [32] at 5µg ml–1, anti-
eotaxin 6H9 at 1:200 [5] or anti-CD3 (Dako) at 1:50. As controls,
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Figure 4
CCR3+ T lymphocytes in nasal polyps and
ulcerative colitis. (a–c) Immunohistochemical
analysis of serial sections of nasal polyp tissue
(a) stained for CD3, (b) for CCR3 and (c)
double-stained for CD3 (red) and CCR3
(blue). Arrowheads designate a CCR3+ T
lymphocyte (T+), a CCR3– T lymphocyte (T–)
and a CCR3+ eosinophil (E). The inset at
bottom right shows a magnification of the
designated CCR3+ T lymphocyte. (d–f)
Immunohistochemical analysis of sequential
colon mucosa tissue sections from a patient
with ulcerative colitis stained for (d) CD3, (e)
CCR3 and (f) eotaxin. Representative fields
are shown.
Nasal polyp Ulcerative colitis
(a) (d)
(b) (e)
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species- and isotype-matched immunoglobulins (Sigma) were used.
After washing, the slides were incubated with biotin-labelled sheep
anti-mouse antibody (Amersham) at 1:800 for 30 min. After additional
washes, the slides were incubated with either streptavidin–biotin–horse-
radish peroxidase (Dako) or streptavidin–biotin–alkaline phosphatase
(Dako) for 30 min. All incubations were performed at room temperature.
The colour reaction was developed with 3-amino-9-ethyl-carbazole
(AEC, Sigma) for peroxidase or with New Fuchsin (Dako) containing lev-
amisole (Dako) for alkaline phosphatase detection. Slides were counter-
stained with Mayer’s haematoxylin. Nasal polyps were double stained
[45]. Sections were first incubated with anti-CD3 monoclonal antibody
as described above, and were then treated with 0.1 M glycine for 5 min
at room temperature before incubation with anti-CCR3 monoclonal anti-
body overnight. CCR3+ cells were detected with Fast Blue (Sigma), an
alternative substrate for alkaline phosphatase. Nuclei were counter-
stained with methyl green. Slides were analysed with a Leitz Dialux
20EB microscope using a 40x magnification and a 0.09 mm2 grid.
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